Sort   by:  
 Page size 
UnknownExcitation properties of computational models of unmyelinated peripheral axons.
Not available
S-EPMC8087387 | biostudies-literature
UnknownResponse and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE study.
Not available
S-EPMC5883881 | biostudies-literature
UnknownSymptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with Clostridioides difficile: Single-Center Study from NE Romania during the COVID-19 Pandemic.
Not available
S-EPMC10375993 | biostudies-literature
UnknownOprozomib in patients with newly diagnosed multiple myeloma.
Not available
S-EPMC6697695 | biostudies-literature
UnknownCross-sectional study on the characteristics of unrecorded alcohol consumption in nine newly independent states between 2013 and 2017.
Not available
S-EPMC8679101 | biostudies-literature
UnknownCervical cancer testing among women aged 30-49 years in the WHO European Region.
Not available
S-EPMC8514175 | biostudies-literature
UnknownEfficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes.
Not available
S-EPMC5729352 | biostudies-literature
Unknown[ZApprO versus ZAPrO: results of a first comparative study].
Not available
S-EPMC10667395 | biostudies-literature
UnknownEfficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma.
Not available
S-EPMC7656926 | biostudies-literature
UnknownCarfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.
Not available
S-EPMC5412871 | biostudies-literature
Sort   by:  
 Page size